Inventor · disambiguated record
Herve Rhinn
Also filed as: RHINN HERVE · RHINN HERVÉ
20 granted patents·15 pending applications·57 citations·filing 2011–2024
93Inventor score
Top patents by PatentIndex Score
35 records- 0195US11661585B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted May 30, 2023·5 cites·19 claims
- 0295US11060113B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·8 cites·15 claims
- 0395US10689625B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2019·Granted Jun 23, 2020·10 cites·17 claims
- 0493US11655460B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted May 23, 2023·3 cites·14 claims
- 0593US10837028B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2019·Granted Nov 17, 2020·9 cites·17 claims
- 0689US11667699B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jun 6, 2023·3 cites·93 claims
- 0786US11802294B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted Oct 31, 2023·2 cites·44 claims
- 0886US11472874B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2019·Granted Oct 18, 2022·3 cites·29 claims
- 0984US11993790B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted May 28, 2024·1 cites·20 claims
- 1083US11136390B2Anti-CD33 antibodies and methods of use thereofALECTOR LLC·Filed 2016·Granted Oct 5, 2021·3 cites·26 claims
- 1182US9290759B2Optimized miRNA constructsABELIOVICH ASA·Filed 2011·Granted Mar 22, 2016·6 cites·8 claims
- 1281US11903985B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Feb 20, 2024·1 cites·24 claims
- 1381US11807849B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2018·Granted Nov 7, 2023·1 cites·41 claims
- 1481US11440957B2Anti-TMEM106B antibodies and methods of use thereofALECTOR LLC·Filed 2018·Granted Sep 13, 2022·1 cites·43 claims
- 1581US2025011783A1Gene therapy for neurodegenerative disordersPREVAIL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1677US2025223365A1Methods of use of anti-sortilin antibodiesALECTOR LLC·Filed 2024·Application pending·0 cites
- 1775US11999974B2Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jun 4, 2024·1 cites·13 claims
- 1874US12331111B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 17, 2025·0 cites·24 claims
- 1974US12331112B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 17, 2025·0 cites·28 claims
- 2072US2024123003A1Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2169US12319734B2Anti-TMEM106B antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Jun 3, 2025·0 cites·27 claims
- 2269US12215149B2Anti-MS4A6A antibodies and methods of use thereofALECTOR LLC·Filed 2022·Granted Feb 4, 2025·0 cites·19 claims
- 2369US12049626B2Gene therapy for neurodegenerative disordersPREVAIL THERAPEUTICS INC·Filed 2020·Granted Jul 30, 2024·0 cites·18 claims
- 2466US2024076362A1Anti-ms4a4a antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 2563US2022251190A1Anti-cd33 antibodies and methods of use thereofALECTOR LLC·Filed 2021·Application pending·0 cites
- 2661US2020392229A1Methods of use of anti-sortilin antibodiesALECTOR LLC·Filed 2020·Application pending·0 cites
- 2760US2024329054A1Soluble cd33 as a biomarker for anti-cd33 efficacyALECTOR LLC·Filed 2024·Application pending·0 cites
- 2859US2024166738A1Anti-tmem106b antibodies for treating and preventing coronavirus infectionsALECTOR LLC·Filed 2022·Application pending·0 cites
- 2959US2024174746A1Anti-tmem106b antibodies and methods of use thereofALECTOR LLC·Filed 2022·Application pending·0 cites
- 3056US2021122817A1Anti-ms4a6a antibodies and methods of use thereofALECTOR LLC·Filed 2019·Application pending·0 cites
- 3153US2022211871A1Gene therapies for lysosomal disordersPREVAIL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3253US2020283800A1Gene therapies for neurodegenerative diseasesPREVAIL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3351US2022010001A1Gene therapies for neurodegenerative diseasePREVAIL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3449US2014323581A1Transcriptome wiring analysis in parkinson's disease and uses thereofUNIV COLUMBIA·Filed 2012·Application pending·0 cites
- 3546US2021261981A1Gene therapies for neurodegenerative diseasesPREVAIL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Herve Rhinn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →